Research Note: Perspectives on the Hierarchy of HIV and Hepatitis C Disease: Consequences for Drug Treatment Program Patients

Injection drug users (IDUs) face an increased risk of acquiring blood borne viral infections, including HIV and the hepatitis C virus (HCV). However, the discrepancy in funding for services to address these two diseases has implications. Although drug treatment programs have played an important role...

Full description

Saved in:
Bibliographic Details
Published in:Journal of drug issues 2010-04, Vol.40 (2), p.517-535
Main Authors: Munoz-Plaza, Corrine, Strauss, Shiela M., Tiburcio, Nelson, Astone-Twerell, Janetta M., Des Jarlais, Don C., Gwadz, Marya, Hagan, Holly, Osborne, Andrew, Rosenblum, Andrew
Format: Article
Language:English
Subjects:
Drug addiction
Hepatitis
HIV
Human immunodeficiency virus
Perceptions
Qualitative research
Risk factors
Substance abuse treatment
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Injection drug users (IDUs) face an increased risk of acquiring blood borne viral infections, including HIV and the hepatitis C virus (HCV). However, the discrepancy in funding for services to address these two diseases has implications. Although drug treatment programs have played an important role in fighting HIV/AIDS, the HCV-related services offered at these programs remain limited. Research from other countries suggests that drug users view HCV as less important than HIV, yet little is known about the extent to which our society's focus on HIV has been adopted within the drug treatment program culture. This qualitative study examines the perceptions of both staff (n = 165) and clients (n = 215) at these programs with regard to HIV and HCV and presents data on how staffs' attitudes toward HCV changed after participating in an HCV training. Clients described a services landscape at drug treatment programs that favors HIV services over those targeting HCV.
ISSN:0022-0426
1945-1369
DOI:10.1177/002204261004000211